loadpatents
Patent applications and USPTO patent grants for Geary; Richard S..The latest application filed is for "conjugated antisense compounds for use in therapy".
Patent | Date |
---|---|
Modulating apolipoprotein (a) expression Grant 11,319,536 - Viney , et al. May 3, 2 | 2022-05-03 |
Conjugated Antisense Compounds for Use in Therapy App 20210169917 - Viney; Nicholas J. ;   et al. | 2021-06-10 |
Modulating Apolipoprotein (a) Expression App 20200362340 - Viney; Nicholas J. ;   et al. | 2020-11-19 |
Modulating apolipoprotein (a) expression Grant 10,557,137 - Viney , et al. Feb | 2020-02-11 |
Modulating Apolipoprotein (a) Expression App 20190136233 - Viney; Nicholas J. ;   et al. | 2019-05-09 |
Conjugated Antisense Compounds For Use In Therapy App 20190046555 - Viney; Nicholas J. ;   et al. | 2019-02-14 |
Compounds and methods for modulating gene expression Grant 9,617,540 - Bhanot , et al. April 11, 2 | 2017-04-11 |
Administering Antisense Oligonucleotides Complementary To Human Apolipoprotein B App 20170096662 - Geary; Richard S. ;   et al. | 2017-04-06 |
Administering antisense oligonucleotides complementary to human apolipoprotein B Grant 9,347,061 - Geary , et al. May 24, 2 | 2016-05-24 |
Oligomeric Compounds And Excipients App 20160010086 - BENNETT; C. FRANK ;   et al. | 2016-01-14 |
Compounds And Methods For Modulating Gene Expression App 20150344879 - Bhanot; Sanjay ;   et al. | 2015-12-03 |
Short antisense compounds with gapmer configuration Grant 9,045,754 - Bhanot , et al. June 2, 2 | 2015-06-02 |
Compounds and methods for modulating expression of DGAT2 Grant 8,969,316 - Bhanot , et al. March 3, 2 | 2015-03-03 |
Compounds And Methods For Modulating Expression Apob App 20150057329 - BHANOT; Sanjay ;   et al. | 2015-02-26 |
Compounds and methods for modulating expression ApoB Grant 8,673,871 - Bhanot , et al. March 18, 2 | 2014-03-18 |
Compounds and methods for modulating expression of PTP1B Grant 8,586,554 - Bhanot , et al. November 19, 2 | 2013-11-19 |
Compounds And Methods For Modulating Expression Of Gccr App 20130165496 - Bhanot; Sanjay ;   et al. | 2013-06-27 |
Compounds and methods for modulating expression of SGLT2 Grant 8,362,232 - Bhanot , et al. January 29, 2 | 2013-01-29 |
Oligomeric Compounds And Excipients App 20120264806 - Bennett; C. Frank ;   et al. | 2012-10-18 |
Compounds And Methods For Modulating Expression Of Gcgr App 20120208864 - Bhanot; Sanjay ;   et al. | 2012-08-16 |
Compounds and methods for modulating expression of GCGR Grant 8,188,059 - Bhanot , et al. May 29, 2 | 2012-05-29 |
Antisense Modulation Of Apolipoprotein B Expression App 20120115926 - Geary; Richard S. ;   et al. | 2012-05-10 |
Compounds and methods for modulating expression of PCSK9 Grant 8,143,230 - Bhanot , et al. March 27, 2 | 2012-03-27 |
Pulsatile Release Compositions And Methods For Enhanced Intestinal Drug Absorption App 20110256217 - Weinbach; Susan ;   et al. | 2011-10-20 |
Compounds And Methods For Modulating Expression Of Sglt2 App 20110065775 - Bhanot; Sanjay ;   et al. | 2011-03-17 |
Administering Antisense Oligonucleotides Complementary To Human Apolipoprotein B App 20100297105 - Geary; Richard S. ;   et al. | 2010-11-25 |
Antisense Modulation Of Apolipoprotein B Expression App 20090326040 - Geary; Richard S. ;   et al. | 2009-12-31 |
Compounds And Methods For Modulating Expression Of Sglt2 App 20090326041 - Bhanot; Sanjay ;   et al. | 2009-12-31 |
Compounds And Methods For Modulating Expression Of Ptp1b App 20090318532 - Bhanot; Sanjay ;   et al. | 2009-12-24 |
Compounds And Methods For Modulating Expression Of Pcsk9 App 20090306005 - Bhanot; Sanjay ;   et al. | 2009-12-10 |
Compounds And Methods For Modulating Expression Apob App 20090306180 - Bhanot; Sanjay ;   et al. | 2009-12-10 |
Compounds And Methods For Modulating Expression Of Gcgr App 20090306179 - Bhanot; Sanjay ;   et al. | 2009-12-10 |
Compounds And Methods For Modulating Expression Of Dgat2 App 20090292006 - Bhanot; Sanjay ;   et al. | 2009-11-26 |
Pulsatile release compositions and methods for enhanced intestinal oligonucleotide drug absorption Grant 7,576,067 - Weinbach , et al. August 18, 2 | 2009-08-18 |
Antisense Modulation of PTP1B Expression App 20090036355 - Bhanot; Sanjay ;   et al. | 2009-02-05 |
Compounds And Methods For Modulating Gene Expression App 20080015162 - Bhanot; Sanjay ;   et al. | 2008-01-17 |
Backbone Modifications To Modulate Oligonucleotide Targeting In Vivo App 20070299028 - Siwkowski; Andrew M. ;   et al. | 2007-12-27 |
Antisense modulation of PTP1B expression App 20060089325 - Bhanot; Sanjay ;   et al. | 2006-04-27 |
Methods for modulating lipoprotein and cholesterol levels in humans App 20060035858 - Geary; Richard S. ;   et al. | 2006-02-16 |
Pulsatile release compositions and methods for enhanced intestinal drug absorption App 20050196443 - Weinbach, Susan ;   et al. | 2005-09-08 |
Pulsatile release compositions and methods for enhanced intestinal drug absorption App 20030124196 - Weinbach, Susan ;   et al. | 2003-07-03 |
Bioadhesive compositions and methods for enhanced intestinal drug absorption App 20030083286 - Teng, Ching-Leou ;   et al. | 2003-05-01 |
Liposomal oligonucleotide compositions for modulating RAS gene expression Grant 6,083,923 - Hardee , et al. July 4, 2 | 2000-07-04 |
Microparticulate pharmaceutical delivery system Grant 5,505,967 - Geary , et al. April 9, 1 | 1996-04-09 |
Microparticulate pharmaceutical delivery system Grant 5,382,435 - Geary , et al. January 17, 1 | 1995-01-17 |
SEC | 0001442730 | Geary Richard S |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.